Clinical trial
Two-arm, Double-blind, Randomized Controlled Trial to Compare Efficacy of Two Digital Software Medical Devices as Interventions for Physical and Mental Health in Patients With Stage I-III Cancer
NCT05227898 is registered in ClinicalTrials.gov with Blue Note Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Two-arm, Double-blind, Randomized Controlled Trial to Compare Efficacy of Two Digital Software Medical Devices as Interventions for Physical and Mental Health in Patients With Stage I-III Cancer
- Lead sponsor
- Blue Note Therapeutics
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 10, 2022
- Completion date
- December 15, 2022
- Enrollment
- 352 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer